Drugs Containing Excipient (Inactive Ingredient) D&C RED NO. 30 ALUMINUM LAKE

Generic drugs containing D&C RED NO. 30 ALUMINUM LAKE excipient

Company	Ingredient	NDC	Excipient
Rite Aid Corporation	dextromethorphan polistirex	11822-0384	D&C RED NO. 30 ALUMINUM LAKE
Rite Aid Corporation	dextromethorphan polistirex	11822-0958	D&C RED NO. 30 ALUMINUM LAKE
Topco Associates LLC	dextromethorphan polistirex	36800-494	D&C RED NO. 30 ALUMINUM LAKE
Padagis Israel Pharmaceuticals Ltd	dextromethorphan polistirex	45802-433	D&C RED NO. 30 ALUMINUM LAKE
Advagen Pharma Limited	metoprolol tartrate	72888-004	D&C RED NO. 30 ALUMINUM LAKE

D&C RED NO. 30 ALUMINUM LAKE Market Analysis and Financial Projection

Here is an analysis of the market dynamics and financial trajectory for the pharmaceutical excipient D&C Red No. 30 Aluminum Lake:

Market Overview

D&C Red No. 30 Aluminum Lake is a colorant used as an excipient in pharmaceuticals and cosmetics. It is part of the broader pharmaceutical excipients market, which is experiencing steady growth.

Market Size and Growth

The global pharmaceutical excipients market was valued at $9.2 billion in 2023 and is projected to reach $12.4 billion by 2029, growing at a CAGR of 5.1% from 2024 to 2029[8]. While specific market size data for D&C Red No. 30 Aluminum Lake is not available, we can analyze its usage trends:

• In Q4 FY2024, 23,823.64 pounds of D&C Red No. 30 Lake were certified by the FDA[1].
• In Q1 FY2025, 8,871.36 pounds were certified[5].

This indicates consistent demand for this excipient, though with some quarterly fluctuations.

Growth Drivers

Several factors are driving growth in the pharmaceutical excipients market, including:

1. Increasing demand for generic and biologic drugs[7]
2. Rising geriatric population requiring more medications[7]
3. Growth of the overall pharmaceutical industry[7]
4. Development of novel drug delivery systems requiring specialized excipients[7]
5. Increasing R&D in the pharmaceutical sector[8]

Challenges

The market faces some challenges:

1. Stringent regulatory framework for excipient approval[7]
2. Potential supply chain disruptions[7]
3. Environmental and sustainability concerns around synthetic colorants[9]

Regional Dynamics

• North America dominates the pharmaceutical excipients market due to high R&D investments[7].
• Asia Pacific is the fastest-growing region, driven by generic drug production in India and China[7].

Future Outlook

The future of pharmaceutical excipients like D&C Red No. 30 Aluminum Lake looks promising:

1. Increasing focus on personalized medicine may drive demand for specialized excipients[8].
2. Growing emphasis on patient-friendly drug formulations could boost use of colorants[8].
3. Sustainability trends may push for more natural alternatives to synthetic lakes[9].

Financial Trajectory

While specific financial data for D&C Red No. 30 Aluminum Lake is not available, we can infer its trajectory based on overall market trends:

1. Steady growth in line with the overall pharmaceutical excipients market (5.1% CAGR)[8].
2. Potential for price fluctuations based on raw material costs and regulatory changes.
3. Possible pressure on margins due to increasing competition and sustainability concerns.

Conclusion

D&C Red No. 30 Aluminum Lake is likely to see continued demand in the pharmaceutical and cosmetic industries. However, its long-term prospects may be influenced by shifts towards natural colorants and stricter regulations. Companies involved in its production should focus on innovation, sustainability, and regulatory compliance to maintain market position.